RT Journal Article
SR Electronic
T1 Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 38
DO 10.1186/s40425-019-0520-5
VO 7
IS 1
A1 Papachristofilou, Alexandros
A1 Hipp, Madeleine M.
A1 Klinkhardt, Ute
A1 Früh, Martin
A1 Sebastian, Martin
A1 Weiss, Christian
A1 Pless, Miklos
A1 Cathomas, Richard
A1 Hilbe, Wolfgang
A1 Pall, Georg
A1 Wehler, Thomas
A1 Alt, Jürgen
A1 Bischoff, Helge
A1 Geißler, Michael
A1 Griesinger, Frank
A1 Kallen, Karl-Josef
A1 Fotin-Mleczek, Mariola
A1 Schröder, Andreas
A1 Scheel, Birgit
A1 Muth, Anke
A1 Seibel, Tobias
A1 Stosnach, Claudia
A1 Doener, Fatma
A1 Hong, Henoch S.
A1 Koch, Sven D.
A1 Gnad-Vogt, Ulrike
A1 Zippelius, Alfred
YR 2019
UL http://jitc.bmj.com/content/7/1/38.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.